GILD
Gilead Sciences Inc
150.90$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -10.8% | 4.8% | 6.8% | 10.0% | 17.1% | 18.7% | 14.9% | 13.0% | 12.6% | 12.8% | 14.3% | 18.2% | 21.1% | 22.8% | 23.5% | 25.3% | 25.5% | 25.5% | 15.2% | 12.3% | 14.0% | 16.7% | 21.9% | 20.8% | 18.5% | 24.2% | 20.7% | 21.4% | 21.7% | 21.2% | |
| 110.8% | 95.2% | 93.2% | 90.0% | 82.9% | 81.3% | 85.1% | 87.0% | 87.4% | 87.2% | 85.7% | 81.8% | 78.9% | 77.2% | 76.5% | 74.7% | 74.5% | 74.5% | 84.8% | 87.7% | 86.0% | 83.3% | 78.1% | 79.2% | 81.5% | 75.8% | 79.3% | 100.0% | 78.3% | 78.8% | |
| 125.4% | 84.8% | 84.6% | 66.8% | 67.7% | 79.4% | 28.9% | 19.0% | 16.9% | 13.7% | 12.7% | 14.0% | 13.5% | 13.4% | 13.5% | 14.7% | 18.1% | 18.9% | 11.5% | 9.2% | 16.8% | 14.3% | 17.7% | 18.1% | 20.4% | 16.9% | 18.2% | 21.1% | 20.5% | 19.7% | |
| 79.9% | 19.3% | 20.5% | 46.3% | 42.3% | 53.5% | 38.8% | 28.8% | 22.9% | 18.7% | 19.0% | 16.7% | 14.9% | 13.5% | 13.1% | 14.8% | 15.1% | 15.2% | 12.0% | 10.5% | 11.2% | 14.9% | 18.3% | 16.0% | 17.5% | 16.5% | 17.9% | 24.0% | 9.2% | 7.4% | |
| 218.9% | 149.7% | 145.1% | 120.6% | 109.6% | 132.9% | 67.7% | 49.0% | 40.1% | 32.5% | 31.6% | 30.7% | 28.5% | 26.9% | 26.6% | 29.5% | 33.2% | 34.1% | 23.5% | 19.7% | 28.0% | 29.2% | 36.0% | 37.6% | 65.0% | 39.5% | 52.4% | 43.5% | 72.5% | 39.1% | |
| -108.1% | -54.5% | -51.8% | -30.6% | -26.8% | -51.6% | 17.4% | -18.3% | 47.4% | 54.7% | -25.1% | 51.2% | 50.2% | 50.3% | 49.8% | 45.2% | 41.3% | 40.4% | 61.3% | 68.0% | 58.0% | 54.1% | 37.1% | 19.1% | 16.5% | 36.3% | 26.9% | 28.0% | 5.8% | 39.7% | |
| 44.9% | 13.8% | 12.2% | 22.3% | 3.1% | 147.0% | 5.1% | 114.8% | 2.9% | 2.5% | 154.2% | 2.5% | 1.2% | 1.0% | 1.4% | 2.4% | 3.7% | 2.7% | 1.7% | 2.1% | 3.2% | 4.3% | 4.9% | 4.4% | 4.0% | 3.7% | 3.4% | 3.5% | 3.4% | 3.5% | |
| -63.2% | -54.9% | -29.1% | -38.8% | -21.4% | 24.6% | 15.7% | -19.3% | 49.6% | 57.3% | -21.1% | 53.7% | 50.1% | 49.9% | 49.2% | 43.5% | 37.2% | 37.6% | 59.7% | 66.4% | 56.3% | 51.8% | 35.2% | 23.0% | 6.8% | 30.3% | 21.3% | 25.3% | 2.4% | 33.3% | |
| -88.0% | 0.2% | 0.6% | 0.5% | 0.6% | 1.8% | 0.3% | -11.0% | 15.6% | 17.2% | 18.2% | 15.5% | 13.2% | 12.5% | 12.9% | 10.3% | 10.7% | 10.3% | 11.2% | 10.9% | 11.9% | 34.0% | 10.6% | -0.9% | 6.4% | 7.6% | 4.6% | -4.6% | 0.7% | 4.4% | |
| -65.0% | -55.1% | -29.6% | -39.3% | -29.0% | 22.4% | 15.4% | -8.3% | 33.9% | 40.1% | -39.3% | 38.2% | 37.1% | 37.6% | 36.5% | 33.4% | 26.7% | 27.5% | 48.6% | 55.5% | 44.4% | 17.7% | 24.7% | 24.0% | 0.5% | 22.8% | 16.8% | 20.9% | 1.7% | 28.9% | |
| -94.6% | -43.0% | -43.1% | -23.1% | -20.6% | -45.3% | 20.4% | 40.4% | 49.2% | 56.4% | 55.6% | 52.4% | 54.2% | 54.0% | 53.9% | 49.6% | 43.8% | 43.4% | 65.6% | 71.8% | 63.2% | 61.0% | 46.6% | 33.7% | 16.7% | 41.5% | 32.4% | 28.0% | 15.4% | 46.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.